Nicotine Replacement: what to check before you give it

Mechanism, simply

Nicotine replacement therapy occupies the same nicotinic acetylcholine receptors that cigarette smoking stimulates, satisfying the physical dependence without the tar, carbon monoxide, and thousands of other combustion products in tobacco smoke. This blunts withdrawal symptoms such as irritability, restlessness, and craving while the patient works on breaking the behavioural habit.

The transdermal patch releases nicotine slowly and continuously over 16 to 24 hours, producing a stable blood level that covers baseline craving throughout the day. Gum, lozenges, and other short-acting forms are absorbed through the oral mucosa within minutes, giving a faster rise and fall suited to a sudden urge rather than steady coverage.

Indications you will see on the ward

You'll encounter nicotine replacement most often in patients admitted to a smoke-free hospital who are heavy smokers and at risk of acute withdrawal during their stay, particularly on medical, surgical, and psychiatric units where a prolonged admission is expected. It's also standard first-line therapy in outpatient smoking cessation programmes, often alongside counselling or bupropion or varenicline.

Postoperative patients are a common group, since nicotine withdrawal can worsen agitation, pain perception, and sleep in the days after surgery. Pregnant patients trying to quit are sometimes offered it too, though that decision weighs the known risks of continued smoking against nicotine exposure and is made with the prescriber, not assumed.

Assessment before administration

Establish an accurate smoking history: cigarettes per day, time to first cigarette after waking, and any prior quit attempts, since this determines the starting patch strength. A patient smoking within 30 minutes of waking is generally started on a higher initial dose than a lighter smoker.

Ask specifically whether the patient intends to keep smoking while wearing the patch or using other forms. This matters clinically, not just behaviourally: continued smoking on top of replacement nicotine adds to total nicotine load rather than replacing it, and increases the risk of toxicity.

Check cardiovascular history, since nicotine itself raises heart rate and blood pressure and constricts vessels; recent myocardial infarction or unstable angina warrants a closer risk discussion with the prescriber before starting, though it is not always an absolute contraindication.

Toxicity and the antidote

There is no specific antidote for nicotine toxicity. Early signs include nausea, vomiting, salivation, abdominal pain, and headache; as levels rise, expect tachycardia followed by bradycardia, hypertension followed by hypotension, tremor, confusion, and in severe cases seizures and respiratory failure.

Management is supportive: remove any remaining patch, gum, or lozenge, monitor cardiac rhythm and respiratory status closely, and treat seizures and hemodynamic instability as they arise. This is the core teaching point for this drug class: the patch supplies the steady baseline and gum or lozenge covers breakthrough cravings, but if the patient is also still smoking, the combined nicotine exposure is not something you manage by simply doubling the replacement dose. The smoking has to stop for the regimen to be dosed safely.

Interactions that matter

Stopping smoking itself changes how several drugs are metabolised, independent of the nicotine replacement. Tobacco smoke induces cytochrome P450 1A2, so when a patient quits, levels of drugs like theophylline, clozapine, and olanzapine can rise and may need dose adjustment even though the nicotine patch itself isn't the interacting agent.

Nicotine can increase circulating catecholamines, which may blunt the effect of some antihypertensives and warrants closer blood pressure monitoring during the switch from smoking to replacement therapy. Caffeine metabolism also slows after quitting, so patients who keep their usual coffee intake may notice increased jitteriness.

What the patient must be told

Explain that continuing to smoke while using the patch, gum, or lozenge does not simply add extra nicotine relief; it raises total nicotine exposure and toxicity risk, and the patch dose is not something to increase on their own to compensate for ongoing cigarette use. The patch gives a steady background level, and gum or lozenge is for topping up cravings in between, not for use alongside continued smoking.

Teach correct technique: rotate patch sites daily to avoid skin irritation, apply to a clean, dry, hairless area, and remove the old patch before applying a new one. For gum, instruct a slow chew-and-park technique against the cheek rather than continuous chewing, since fast chewing releases nicotine too quickly and causes hiccups, nausea, or a burning throat rather than better craving control.